Report cover image

Global Non-invasive Prenatal Diagnostics Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750314

Description

Global Non-invasive Prenatal Diagnostics Databank Market Report


The Non-invasive Prenatal Diagnostics market was valued at $4,215.6 Million in 2022, and is projected to reach $9,035.7 Million by 2031 growing at a CAGR of 8.90% from 2023 to 2031. 13-24 Weeks segment is expected to be the highest contributor to this market, with $2,221.5 Million in 2022, and is anticipated to reach $4,609.1 Million by 2031, registering a CAGR of 8.50%. 0-12 Weeks segment is anticipated to reach $2,263.2 Million by 2031 with the highest CAGR of 9.32%. 13-24 Weeks and 0-12 Weeks segments collectively expected to account for about 76.9% share of the Non-invasive Prenatal Diagnostics market in 2022, with the former constituting around 52.7% share. 0-12 Weeks and 25-36 Weeks segments are expected to witness significant growth rates at a CAGR of 9.32% and 9.32% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 47.3% in the overall Non-invasive Prenatal Diagnostics market in 2022, and is anticipated to reach 49.0% by 2031.

Table of Contents

100 Pages
1. Global Non-invasive Prenatal Diagnostics Market, By Gestation Period
1.1. Overview
1.2. 0-12 Weeks
1.2.1 0-12 Weeks Market, By Region
1.2.1.1 North America 0-12 Weeks Market, By Country
1.2.1.2 Europe 0-12 Weeks Market, By Country
1.2.1.3 Asia-Pacific 0-12 Weeks Market, By Country
1.2.1.4 Rest of World 0-12 Weeks Market, By Country
1.3. 13-24 Weeks
1.3.1 13-24 Weeks Market, By Region
1.3.1.1 North America 13-24 Weeks Market, By Country
1.3.1.2 Europe 13-24 Weeks Market, By Country
1.3.1.3 Asia-Pacific 13-24 Weeks Market, By Country
1.3.1.4 Rest of World 13-24 Weeks Market, By Country
1.4. 25-36 Weeks
1.4.1 25-36 Weeks Market, By Region
1.4.1.1 North America 25-36 Weeks Market, By Country
1.4.1.2 Europe 25-36 Weeks Market, By Country
1.4.1.3 Asia-Pacific 25-36 Weeks Market, By Country
1.4.1.4 Rest of World 25-36 Weeks Market, By Country
2. Global Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
2.1. Overview
2.2. High & Average Risk
2.2.1 High & Average Risk Market, By Region
2.2.1.1 North America High & Average Risk Market, By Country
2.2.1.2 Europe High & Average Risk Market, By Country
2.2.1.3 Asia-Pacific High & Average Risk Market, By Country
2.2.1.4 Rest of World High & Average Risk Market, By Country
2.3. Low Risk
2.3.1 Low Risk Market, By Region
2.3.1.1 North America Low Risk Market, By Country
2.3.1.2 Europe Low Risk Market, By Country
2.3.1.3 Asia-Pacific Low Risk Market, By Country
2.3.1.4 Rest of World Low Risk Market, By Country
3. Global Non-invasive Prenatal Diagnostics Market, By Method
3.1. Overview
3.2. Ultrasound Detection
3.2.1 Ultrasound Detection Market, By Region
3.2.1.1 North America Ultrasound Detection Market, By Country
3.2.1.2 Europe Ultrasound Detection Market, By Country
3.2.1.3 Asia-Pacific Ultrasound Detection Market, By Country
3.2.1.4 Rest of World Ultrasound Detection Market, By Country
3.3. Biochemical Screening Tests
3.3.1 Biochemical Screening Tests Market, By Region
3.3.1.1 North America Biochemical Screening Tests Market, By Country
3.3.1.2 Europe Biochemical Screening Tests Market, By Country
3.3.1.3 Asia-Pacific Biochemical Screening Tests Market, By Country
3.3.1.4 Rest of World Biochemical Screening Tests Market, By Country
3.4. Cell-free DNA in Maternal Plasma Tests
3.4.1 Cell-free DNA in Maternal Plasma Tests Market, By Region
3.4.1.1 North America Cell-free DNA in Maternal Plasma Tests Market, By Country
3.4.1.2 Europe Cell-free DNA in Maternal Plasma Tests Market, By Country
3.4.1.3 Asia-Pacific Cell-free DNA in Maternal Plasma Tests Market, By Country
3.4.1.4 Rest of World Cell-free DNA in Maternal Plasma Tests Market, By Country
4. Global Non-invasive Prenatal Diagnostics Market, By Technology
4.1. Overview
4.2. NGS
4.2.1 NGS Market, By Region
4.2.1.1 North America NGS Market, By Country
4.2.1.2 Europe NGS Market, By Country
4.2.1.3 Asia-Pacific NGS Market, By Country
4.2.1.4 Rest of World NGS Market, By Country
4.3. Array Technology
4.3.1 Array Technology Market, By Region
4.3.1.1 North America Array Technology Market, By Country
4.3.1.2 Europe Array Technology Market, By Country
4.3.1.3 Asia-Pacific Array Technology Market, By Country
4.3.1.4 Rest of World Array Technology Market, By Country
4.4. PCR
4.4.1 PCR Market, By Region
4.4.1.1 North America PCR Market, By Country
4.4.1.2 Europe PCR Market, By Country
4.4.1.3 Asia-Pacific PCR Market, By Country
4.4.1.4 Rest of World PCR Market, By Country
4.5. Other Technologies
4.5.1 Other Technologies Market, By Region
4.5.1.1 North America Other Technologies Market, By Country
4.5.1.2 Europe Other Technologies Market, By Country
4.5.1.3 Asia-Pacific Other Technologies Market, By Country
4.5.1.4 Rest of World Other Technologies Market, By Country
5. Global Non-invasive Prenatal Diagnostics Market, By Region
5.1. Overview
5.2. North America
5.2.1 North America Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.2.2 North America Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.2.3 North America Non-invasive Prenatal Diagnostics Market, By Method
5.2.4 North America Non-invasive Prenatal Diagnostics Market, By Technology
5.2.5 North America Non-invasive Prenatal Diagnostics Market, By Country
5.2.5.1 U.S.
5.2.5.1.1 U.S. Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.2.5.1.2 U.S. Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.2.5.1.3 U.S. Non-invasive Prenatal Diagnostics Market, By Method
5.2.5.1.4 U.S. Non-invasive Prenatal Diagnostics Market, By Technology
5.2.5.2 Canada
5.2.5.2.1 Canada Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.2.5.2.2 Canada Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.2.5.2.3 Canada Non-invasive Prenatal Diagnostics Market, By Method
5.2.5.2.4 Canada Non-invasive Prenatal Diagnostics Market, By Technology
5.3. Europe
5.3.1 Europe Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.3.2 Europe Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.3.3 Europe Non-invasive Prenatal Diagnostics Market, By Method
5.3.4 Europe Non-invasive Prenatal Diagnostics Market, By Technology
5.3.5 Europe Non-invasive Prenatal Diagnostics Market, By Country
5.3.5.1 Germany
5.3.5.1.1 Germany Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.3.5.1.2 Germany Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.3.5.1.3 Germany Non-invasive Prenatal Diagnostics Market, By Method
5.3.5.1.4 Germany Non-invasive Prenatal Diagnostics Market, By Technology
5.3.5.2 U.K.
5.3.5.2.1 U.K. Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.3.5.2.2 U.K. Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.3.5.2.3 U.K. Non-invasive Prenatal Diagnostics Market, By Method
5.3.5.2.4 U.K. Non-invasive Prenatal Diagnostics Market, By Technology
5.3.5.3 France
5.3.5.3.1 France Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.3.5.3.2 France Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.3.5.3.3 France Non-invasive Prenatal Diagnostics Market, By Method
5.3.5.3.4 France Non-invasive Prenatal Diagnostics Market, By Technology
5.3.5.4 Italy
5.3.5.4.1 Italy Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.3.5.4.2 Italy Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.3.5.4.3 Italy Non-invasive Prenatal Diagnostics Market, By Method
5.3.5.4.4 Italy Non-invasive Prenatal Diagnostics Market, By Technology
5.3.5.5 Spain
5.3.5.5.1 Spain Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.3.5.5.2 Spain Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.3.5.5.3 Spain Non-invasive Prenatal Diagnostics Market, By Method
5.3.5.5.4 Spain Non-invasive Prenatal Diagnostics Market, By Technology
5.3.5.6 Rest of Europe
5.3.5.6.1 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.3.5.6.2 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.3.5.6.3 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Method
5.3.5.6.4 Rest of Europe Non-invasive Prenatal Diagnostics Market, By Technology
5.4. Asia-Pacific
5.4.1 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.4.2 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.4.3 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Method
5.4.4 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Technology
5.4.5 Asia-Pacific Non-invasive Prenatal Diagnostics Market, By Country
5.4.5.1 China
5.4.5.1.1 China Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.4.5.1.2 China Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.4.5.1.3 China Non-invasive Prenatal Diagnostics Market, By Method
5.4.5.1.4 China Non-invasive Prenatal Diagnostics Market, By Technology
5.4.5.2 Japan
5.4.5.2.1 Japan Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.4.5.2.2 Japan Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.4.5.2.3 Japan Non-invasive Prenatal Diagnostics Market, By Method
5.4.5.2.4 Japan Non-invasive Prenatal Diagnostics Market, By Technology
5.4.5.3 South Korea
5.4.5.3.1 South Korea Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.4.5.3.2 South Korea Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.4.5.3.3 South Korea Non-invasive Prenatal Diagnostics Market, By Method
5.4.5.3.4 South Korea Non-invasive Prenatal Diagnostics Market, By Technology
5.4.5.4 India
5.4.5.4.1 India Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.4.5.4.2 India Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.4.5.4.3 India Non-invasive Prenatal Diagnostics Market, By Method
5.4.5.4.4 India Non-invasive Prenatal Diagnostics Market, By Technology
5.4.5.5 Singapore
5.4.5.5.1 Singapore Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.4.5.5.2 Singapore Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.4.5.5.3 Singapore Non-invasive Prenatal Diagnostics Market, By Method
5.4.5.5.4 Singapore Non-invasive Prenatal Diagnostics Market, By Technology
5.4.5.6 Rest of Asia
5.4.5.6.1 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.4.5.6.2 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.4.5.6.3 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Method
5.4.5.6.4 Rest of Asia Non-invasive Prenatal Diagnostics Market, By Technology
5.5. Rest of World
5.5.1 Rest of World Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.5.2 Rest of World Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.5.3 Rest of World Non-invasive Prenatal Diagnostics Market, By Method
5.5.4 Rest of World Non-invasive Prenatal Diagnostics Market, By Technology
5.5.5 Rest of World Non-invasive Prenatal Diagnostics Market, By Country
5.5.5.1 Brazil
5.5.5.1.1 Brazil Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.5.5.1.2 Brazil Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.5.5.1.3 Brazil Non-invasive Prenatal Diagnostics Market, By Method
5.5.5.1.4 Brazil Non-invasive Prenatal Diagnostics Market, By Technology
5.5.5.2 Mexico
5.5.5.2.1 Mexico Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.5.5.2.2 Mexico Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.5.5.2.3 Mexico Non-invasive Prenatal Diagnostics Market, By Method
5.5.5.2.4 Mexico Non-invasive Prenatal Diagnostics Market, By Technology
5.5.5.3 South Africa
5.5.5.3.1 South Africa Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.5.5.3.2 South Africa Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.5.5.3.3 South Africa Non-invasive Prenatal Diagnostics Market, By Method
5.5.5.3.4 South Africa Non-invasive Prenatal Diagnostics Market, By Technology
5.5.5.4 Australia
5.5.5.4.1 Australia Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.5.5.4.2 Australia Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.5.5.4.3 Australia Non-invasive Prenatal Diagnostics Market, By Method
5.5.5.4.4 Australia Non-invasive Prenatal Diagnostics Market, By Technology
5.5.5.5 ROW Countries
5.5.5.5.1 ROW Countries Non-invasive Prenatal Diagnostics Market, By Gestation Period
5.5.5.5.2 ROW Countries Non-invasive Prenatal Diagnostics Market, By Pregnancy Risk
5.5.5.5.3 ROW Countries Non-invasive Prenatal Diagnostics Market, By Method
5.5.5.5.4 ROW Countries Non-invasive Prenatal Diagnostics Market, By Technology
ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 2. 0-12 Weeks Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World 0-12 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 7. 13-24 Weeks Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World 13-24 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 12. 25-36 Weeks Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World 25-36 Weeks Market Value, By Country, 2022-2031, Million USD
TABLE 17. Global Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 18. High & Average Risk Market Value, By Region, 2022-2031, Million USD
TABLE 19. North America High & Average Risk Market Value, By Country, 2022-2031, Million USD
TABLE 20. Europe High & Average Risk Market Value, By Country, 2022-2031, Million USD
TABLE 21. Asia-Pacific High & Average Risk Market Value, By Country, 2022-2031, Million USD
TABLE 22. Rest of World High & Average Risk Market Value, By Country, 2022-2031, Million USD
TABLE 23. Low Risk Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America Low Risk Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe Low Risk Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific Low Risk Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World Low Risk Market Value, By Country, 2022-2031, Million USD
TABLE 28. Global Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 29. Ultrasound Detection Market Value, By Region, 2022-2031, Million USD
TABLE 30. North America Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
TABLE 31. Europe Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
TABLE 32. Asia-Pacific Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
TABLE 33. Rest of World Ultrasound Detection Market Value, By Country, 2022-2031, Million USD
TABLE 34. Biochemical Screening Tests Market Value, By Region, 2022-2031, Million USD
TABLE 35. North America Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
TABLE 36. Europe Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
TABLE 37. Asia-Pacific Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
TABLE 38. Rest of World Biochemical Screening Tests Market Value, By Country, 2022-2031, Million USD
TABLE 39. Cell-free DNA in Maternal Plasma Tests Market Value, By Region, 2022-2031, Million USD
TABLE 40. North America Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
TABLE 41. Europe Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
TABLE 42. Asia-Pacific Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
TABLE 43. Rest of World Cell-free DNA in Maternal Plasma Tests Market Value, By Country, 2022-2031, Million USD
TABLE 44. Global Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 45. NGS Market Value, By Region, 2022-2031, Million USD
TABLE 46. North America NGS Market Value, By Country, 2022-2031, Million USD
TABLE 47. Europe NGS Market Value, By Country, 2022-2031, Million USD
TABLE 48. Asia-Pacific NGS Market Value, By Country, 2022-2031, Million USD
TABLE 49. Rest of World NGS Market Value, By Country, 2022-2031, Million USD
TABLE 50. Array Technology Market Value, By Region, 2022-2031, Million USD
TABLE 51. North America Array Technology Market Value, By Country, 2022-2031, Million USD
TABLE 52. Europe Array Technology Market Value, By Country, 2022-2031, Million USD
TABLE 53. Asia-Pacific Array Technology Market Value, By Country, 2022-2031, Million USD
TABLE 54. Rest of World Array Technology Market Value, By Country, 2022-2031, Million USD
TABLE 55. PCR Market Value, By Region, 2022-2031, Million USD
TABLE 56. North America PCR Market Value, By Country, 2022-2031, Million USD
TABLE 57. Europe PCR Market Value, By Country, 2022-2031, Million USD
TABLE 58. Asia-Pacific PCR Market Value, By Country, 2022-2031, Million USD
TABLE 59. Rest of World PCR Market Value, By Country, 2022-2031, Million USD
TABLE 60. Other Technologies Market Value, By Region, 2022-2031, Million USD
TABLE 61. North America Other Technologies Market Value, By Country, 2022-2031, Million USD
TABLE 62. Europe Other Technologies Market Value, By Country, 2022-2031, Million USD
TABLE 63. Asia-Pacific Other Technologies Market Value, By Country, 2022-2031, Million USD
TABLE 64. Rest of World Other Technologies Market Value, By Country, 2022-2031, Million USD
TABLE 65. Global Non-invasive Prenatal Diagnostics Market Value, By Region, 2022-2031, Million USD
TABLE 66. North America Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 67. North America Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 68. North America Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 69. North America Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 70. North America Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 71. U.S. Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 72. U.S. Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 73. U.S. Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 74. U.S. Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 75. Canada Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 76. Canada Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 77. Canada Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 78. Canada Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 79. Europe Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 80. Europe Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 81. Europe Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 82. Europe Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 83. Europe Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 84. Germany Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 85. Germany Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 86. Germany Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 87. Germany Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 88. U.K. Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 89. U.K. Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 90. U.K. Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 91. U.K. Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 92. France Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 93. France Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 94. France Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 95. France Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 96. Italy Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 97. Italy Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 98. Italy Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 99. Italy Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 100. Spain Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 101. Spain Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 102. Spain Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 103. Spain Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 104. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 105. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 106. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 107. Rest of Europe Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 108. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 109. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 110. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 111. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 112. Asia-Pacific Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 113. China Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 114. China Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 115. China Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 116. China Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 117. Japan Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 118. Japan Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 119. Japan Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 120. Japan Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 121. South Korea Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 122. South Korea Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 123. South Korea Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 124. South Korea Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 125. India Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 126. India Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 127. India Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 128. India Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 129. Singapore Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 130. Singapore Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 131. Singapore Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 132. Singapore Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 133. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 134. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 135. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 136. Rest of Asia Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 137. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 138. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 139. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 140. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 141. Rest of World Non-invasive Prenatal Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 142. Brazil Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 143. Brazil Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 144. Brazil Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 145. Brazil Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 146. Mexico Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 147. Mexico Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 148. Mexico Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 149. Mexico Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 150. South Africa Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 151. South Africa Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 152. South Africa Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 153. South Africa Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 154. Australia Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 155. Australia Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 156. Australia Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 157. Australia Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 158. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Gestation Period, 2022-2031, Million USD
TABLE 159. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Pregnancy Risk, 2022-2031, Million USD
TABLE 160. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Method, 2022-2031, Million USD
TABLE 161. ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD
ROW Countries Non-invasive Prenatal Diagnostics Market Value, By Technology, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us